Summ. Background Data We previously reported, in a study of 608 patien
ts, that the gastric bypass operation (GB) controls type 2 diabetes me
llitus in the morbidly obese patient more effectively than any medical
therapy. Further, we showed for the first time that it was possible t
o reduce the mortality from diabetes; GB reduced the chance of dying f
rom 4.5% per year to 1 % per year. This control of diabetes has been a
scribed to the weight loss induced by the operation. These studies, in
weight-stable women, were designed to determine whether weight loss w
as really the important factor. Methods Fasting plasma insulin, fastin
g plasma glucose. minimal model-derived insulin sensitivity and leptin
levels were measured in carefully matched cohorts: six women who had
undergone GB and had been stable at their lowered weight 24 to 30 mont
hs after surgery Versus a control group of six women who did not under
go surgery and were similarly weight-stable. The two groups were match
ed in age, percentage of fat, body mass index, waist circumference, an
d aerobic capacity. Results Even though the two groups of patients wer
e closely matched in weight, age, percentage of fat, and even aerobic
capacity, and with both groups maintaining stable weights, the surgica
l group demonstrated significantly lower levels of serum leptin, fasti
ng plasma insulin, and fasting plasma glucose compared to the control
group. Similarly, minimal model-derived insulin sensitivity was signif
icantly higher in the surgical group. Finally, self-reported food inta
ke was significantly lower in the surgical group. Conclusions Weight l
oss is not the reason why GB controls diabetes mellitus. Instead, bypa
ssing the foregut and reducing food intake produce the profound long-t
erm alterations in glucose metabolism and insulin action. These findin
gs suggest that our current paradigms of type 2 diabetes mellitus dese
rve review. The critical lesion may lie in abnormal signals from the g
ut.